ClinicalTrials.gov record
Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma
ACTIVE NOT RECRUITING · NCT01783535
Trial record
NCT IDNCT01783535
Status
ACTIVE NOT RECRUITING
Study type
INTERVENTIONAL
Phase
PHASE2
Enrollment
174
Conditions
Retinoblastoma
Interventions
vincristine, topotecan, filgrastim, PEG-filgrastim, carboplatin, focal therapy, etoposide, cyclophosphamide, MESNA, doxorubicin, enucleation, external beam radiation or proton beam radiation
Locations
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Indexed topics
Last update
2026-06-03